Provenance du réseau au premier degré de Wayne Bowler
Entité | Type d'entité | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 25 | |
Kyowa Kirin International Plc
Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom.
10
| Subsidiary | Pharmaceuticals: Major | 10 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Wayne Bowler via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Pharmaceuticals: Major | Director/Board Member | |
KIRIN HOLDINGS COMPANY, LIMITED | Beverages: Alcoholic | President Comptroller/Controller/Auditor | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
Helsinn Healthcare SA
Helsinn Healthcare SA Pharmaceuticals: MajorHealth Technology Helsinn Healthcare SA develops and provides licenses for drugs. The firm offers services to oncology, cancer supportive care, pain and inflammation, gastrointestinal fields. The company was founded by Gabriele Braglia in 1976 and is headquartered in Pazzallo, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
MINEBEAMITSUMI INC. | Metal Fabrication | Director/Board Member | |
SHOWA SHELL SEKIYU KK | Oil Refining/Marketing | Chief Operating Officer | |
Mitsubishi Chemical Corp.
Mitsubishi Chemical Corp. Chemicals: Major DiversifiedProcess Industries Mitsubishi Chemical Corp. engages in the manufacture and sale of performance products and industrial materials. Its products and materials are used in automobiles and aircrafts; packaging, labels and films; IT, electronics and displays; environment and energy; and medical, food and bio products. The company was founded on August 31, 1933 and is headquartered in Tokyo, Japan. | Chemicals: Major Diversified | Director/Board Member | |
HAMAMATSU PHOTONICS K.K. | Electronic Components | Director/Board Member | |
ROLAND DG CORPORATION | Industrial Machinery | Independent Dir/Board Member | |
Anderson Mori & Tomotsune
Anderson Mori & Tomotsune Miscellaneous Commercial ServicesCommercial Services Anderson Mori & Tomotsune is a Japanese company that provides legal services. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
University of Bristol | College/University | Doctorate Degree | |
Endocrine Pharmaceuticals Ltd.
Endocrine Pharmaceuticals Ltd. Miscellaneous Commercial ServicesCommercial Services Endocrine Pharmaceuticals Ltd. engages in the development of hormonal drugs. If focuses on the research of micrin a naturally occurring mammalian hormonal inhibitor of tissue masses and cellular integrity. The company is headquartered in Tadley, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Coventry University | College/University | Undergraduate Degree | |
Hematech, Inc.
Hematech, Inc. Pharmaceuticals: MajorHealth Technology Part of MeritCare Health System, Hematech, Inc. develops pharmaceutical products. The company is based in Sioux Falls, SD. Hematech was acquired by Sanford Health Corp. from Kirin Holdings Co., Ltd. on December 31, 2012. | Pharmaceuticals: Major | Director of Finance/CFO | |
University of Tokyo | College/University | Undergraduate Degree Corporate Officer/Principal | |
Chiba University | College/University | Corporate Officer/Principal | |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Pharmaceuticals: Major | Corporate Officer/Principal | |
King's College London | College/University | Doctorate Degree | |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Vifor Pharma Management AG
Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
Helsinn Holding SA
Helsinn Holding SA Hospital/Nursing ManagementHealth Services Helsinn Holding SA is a holding Swiss company that provides cancer services through its subsidiaries. The private company is based in Lugano, Switzerland and has subsidiaries in Switzerland and Ireland. The company was founded in 1976 by Gabriele Edoardo Braglia. Riccardo Braglia has been the CEO of the company since 2002. | Hospital/Nursing Management | Director/Board Member | |
Kyowa Hakko Bio Co., Ltd.
Kyowa Hakko Bio Co., Ltd. Pharmaceuticals: OtherHealth Technology Kyowa Hakko Bio Co. Ltd. engages in the manufacture and sale of amino acids and nucleic acids for pharmaceutical and industrial use. The company was founded on October 1, 2008 and is headquartered in Tokyo, Japan. | Pharmaceuticals: Other | Director/Board Member Chief Executive Officer | |
BSP Pharmaceuticals SpA
BSP Pharmaceuticals SpA Pharmaceuticals: MajorHealth Technology BSP Pharmaceuticals SpA develops and manufactures anticancer drugs. It offers development, clinical supply, commercial supply, and analytical services. The company was founded by Aldo Braca in July 2006 and is headquartered in Latina Scalo, Italy. | Pharmaceuticals: Major | Director/Board Member | |
Japan Science & Technology Agency
Japan Science & Technology Agency General GovernmentGovernment Japan Science & Technology Agency implements the government's science and technology policy and basic plan. It also provides infrastructure of science and technology information and creates awareness and understanding of science and technology-related issues. The agency focuses on the following priority areas: Green Innovation, Life Innovation, Nanotechnology and Materials, Information and Communications Technology, and Science and Technology for Society. The agency was founded in October 1996 and is headquartered in Kawaguchi, Japan. | General Government | Corporate Officer/Principal | |
Showa Yokkaichi Sekiyu Co., Ltd.
Showa Yokkaichi Sekiyu Co., Ltd. Oil Refining/MarketingEnergy Minerals Part of Shell Plc, Showa Yokkaichi Sekiyu Co., Ltd. engages in processing and wholesale of petroleum products and petrochemicals. The company is based in Yokkaichi, Japan. | Oil Refining/Marketing | Director/Board Member | |
Showa Shell Solar KK | Director/Board Member | ||
Solar Frontier KK
Solar Frontier KK Building ProductsProducer Manufacturing Solar Frontier KK operates as a CIS thin-film solar energy company by production, sales and technology. The firm’s products include R&D, module production, supply, system solutions, power production, operation and maintenance. The company was founded in 2006 and is headquartered in Tokyo, Japan. | Building Products | Director/Board Member | |
Pharmacia & Upjohn SpA | Corporate Officer/Principal | ||
Nagoya University of Commerce & Business | College/University | Corporate Officer/Principal | |
CYFUSE BIOMEDICAL K.K. | Biotechnology | Director/Board Member | |
Cell Therapy Ltd.
Cell Therapy Ltd. BiotechnologyHealth Technology Cell Therapy Ltd. produces regenerative medicines using adult stem cells to treat heart failure. Its product HeartCel, a stem cell therapy that offers improved outcomes for heart failure patients by reducing the size of heart scar, improving heart function, quality of life and reducing mortality. The firm develops therapies based on the adult mesenchymal stromal cells technology platform. The firm’s regenerative therapies will focus on curing the cause of the disease, rather than only treating the symptoms. The company was founded in 2009 by Martin John Evans and Ajan Trevor Reginald and is headquartered in Cardiff, the United Kingdom. | Biotechnology | Director/Board Member | |
University of Tokyo Faculty of Law & Graduate Schools for Law | College/University | Graduate Degree | |
MEREO BIOPHARMA GROUP PLC | Biotechnology | Director/Board Member | |
Graduate School of Pharmaceutical Sciences University of Tokyo | College/University | Graduate Degree | |
Policy Alternatives Research Institute | Director/Board Member | ||
Helsinn Healthcare SA /Venture/
Helsinn Healthcare SA /Venture/ Investment ManagersFinance 3B FUTURE HEALTH VENTURES SARL (3B Future Health Ventures) is a venture capital subsidiary of Helsinn Healthcare SA founded in 2016. The firm is headquartered in Monaco, Luxembourg. | Investment Managers | Private Equity Investor | |
Fujifilm Kyowa Kirin Biologics Co., Ltd.
Fujifilm Kyowa Kirin Biologics Co., Ltd. BiotechnologyHealth Technology Fujifilm Kyowa Kirin Biologics Co., Ltd. develops and produces biopharmaceutical products and drugs. The joint venture company is based in Tokyo, Japan. It was founded in 2012, and the CEO is Yoshifumi Torii. | Biotechnology | Chief Executive Officer | |
FSI SGR SpA
FSI SGR SpA Investment ManagersFinance FSI SGR SpA (FSI) also known as Fondo Strategico Italiano, is an independent private equity firm. The firm was founded in 2016 and is headquartered in Milan, Italy. | Investment Managers | Private Equity Investor | |
Micromega Ltd.
Micromega Ltd. Miscellaneous Commercial ServicesCommercial Services Micromega Ltd. provides business support services. The private company is based in London, UK. The British company was founded by Francesco Granata. | Miscellaneous Commercial Services | Founder | |
Gakushuin University Law School | College/University | Corporate Officer/Principal | |
UTILITY therapeutics Ltd.
UTILITY therapeutics Ltd. Pharmaceuticals: GenericHealth Technology Utility Therapeutics Ltd. is a British company that has exclusive US commercial rights to two European-approved antibiotics, mecillinam and an oral prodrug of mecillinam, for the treatment of urinary tract infections (UTI). The private company is based in Altrincham, UK and was founded in 2018 by Rasmus Toft-Kehler, Morten Otto Alexander Sommer, Peter Aksel Villadsen. Mecillinam is being developed as a first-line therapy for complicated UTI in the hospital setting, while the oral prodrug is being developed for uncomplicated UTI. The company has received the FDA's Qualified Infectious Disease Product (QIDP) designation for the treatment of UTI. Utility Therapeutics is committed to developing antibiotics that meet urgent treatment needs for multi-drug resistant infections. | Pharmaceuticals: Generic | Director/Board Member | |
NUCB Business School | College/University | Corporate Officer/Principal | |
ORCHARD THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Diadem SpA
Diadem SpA Miscellaneous Commercial ServicesCommercial Services Diadem Srl predicts, monitors, diagnosis and drug development for Alzheimer?s disease. focuses on specific research on early peripheral markers of Alzheimer's disease into technology. The company was founded by Maurizio Memo and Daniela Uberti in June 2012 and is headquartered in Brescia, Italy. | Miscellaneous Commercial Services | Director/Board Member | |
Centus Biotherapeutics Ltd.
Centus Biotherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Centus Biotherapeutics Ltd. is a British company that develops and manufactures biologic products. The joint venture company is based in Cambridge, UK. The company was founded in 2015. | Pharmaceuticals: Major | Director/Board Member | |
ARECOR THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member | |
CORE CONCEPT TECHNOLOGIES INC. | Information Technology Services | Director/Board Member |
Statistiques
Internationale
Japon | 24 |
Royaume-Uni | 13 |
Etats-Unis | 7 |
Suisse | 5 |
Italie | 5 |
Sectorielle
Health Technology | 21 |
Consumer Services | 11 |
Commercial Services | 5 |
Producer Manufacturing | 4 |
Energy Minerals | 3 |
Opérationnelle
Director/Board Member | 80 |
Corporate Officer/Principal | 47 |
Independent Dir/Board Member | 17 |
Chief Executive Officer | 13 |
President | 12 |
Relations les plus connectées
Insiders | |
---|---|
David Ebsworth | 26 |
Francesco Granata | 24 |
Allan Mark Watson | 11 |
Yoshihisa Suzuki | 10 |
Takeshi Minakata | 9 |
Abdul Mullick | 9 |
Takashi Oyamada | 8 |
Takuo Hirose | 7 |
Akira Morita | 7 |
Jeremy Morgan | 5 |
Jun Arai | 5 |
Yuko Haga | 4 |
Wataru Murata | 4 |
Yasuo Fujii | 4 |
Callum Munro Spreng | 4 |
- Bourse
- Insiders
- Wayne Bowler
- Connexions Sociétés